BXP
60
5
MAT
41
-4
COST
66
3
HCA
48
2
EXPD
48
-5
XRX
42
-3
MCHP
43
-11
ED
55
3
SO
62
3
SLB
53
-3
VRSN
58
2
PGR
68
3
RSG
76
2
VRSK
82
2
HPQ
66
6
NEE
59
5
MOS
43
-5
DNB
82
-2
BBY
42
2
EMC
56
-3
BXP
60
5
MAT
41
-4
COST
66
3
HCA
48
2
EXPD
48
-5
XRX
42
-3
MCHP
43
-11
ED
55
3
SO
62
3
SLB
53
-3
VRSN
58
2
PGR
68
3
RSG
76
2
VRSK
82
2
HPQ
66
6
NEE
59
5
MOS
43
-5
DNB
82
-2
BBY
42
2
EMC
56
-3
Financhill
Back

KraneShares Bosera MSCIChinaA50CntIdETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
36

KBA
KraneShares Bosera MSCIChinaA50CntIdETF

Last Price:
24.06
Seasonality Move:
-1.12%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
36
KraneShares Bosera MSCIChinaA50CntIdETF (KBA) is a Sell

Is KraneShares Bosera MSCIChinaA50CntIdETF a Buy, Sell or Hold?

  • The current KraneShares Bosera MSCIChinaA50CntIdETF [KBA] share price is $24.06. The Score for KBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • KBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KBA Stock Price Chart

What is KraneShares Bosera MSCIChinaA50CntIdETF's stock price today?

  • The KraneShares Bosera MSCIChinaA50CntIdETF share price today is $24.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KBA is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

KBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 45.14 Sell
Chaikin Money Flow: 97945 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.11 - 25.41) Sell
Bollinger Bands (100): (21.06 - 25.52) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

KBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.07 Sell
20-day SMA: 24.66 Sell
50-day SMA: 25.1 Sell
200-day SMA: 22.51 Buy
8-day EMA: 24.05 Buy
20-day EMA: 24.48 Sell
50-day EMA: 24.41 Sell
200-day EMA: 23.11 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

KraneShares Bosera MSCIChinaA50CntIdETF Earnings Growth & KBA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

KraneShares Bosera MSCIChinaA50CntIdETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):